Radiofrequency Eye Device Market Report 2025

The radiofrequency eye device market size has grown rapidly in recent years. It will grow from $0.86 billion in 2024 to $1.01 billion in 2025 at a compound annual growth rate (CAGR) of 16.5%. The growth during the historic period was driven by the increasing prevalence of ophthalmic disorders such as dry eye syndrome, a rising geriatric population susceptible to vision and skin concerns, wider adoption of minimally invasive cosmetic procedures, higher incidence of meibomian gland dysfunction, and greater penetration of specialized eye clinics and dermatology centers.

The radiofrequency eye device market size is expected to see rapid growth in the next few years. It will grow to $1.83 billion in 2029 at a compound annual growth rate (CAGR) of 16.1%. The growth during the forecast period is expected to be supported by rising adoption of at-home eye care and wellness devices, continued technological progress in radiofrequency treatment systems, increasing demand from urban populations experiencing digital eye strain, expanding e-commerce platforms for eye care solutions, and stronger government and private initiatives promoting eye health. Key trends anticipated in the forecast period include advancements in artificial intelligence for eye diagnostics, greater use of at-home eye care technologies, application of nanotechnology for precision treatments, integration of AI-powered skin and eye diagnostic tools, and adoption of robotics for eye care and surgical assistance.

The increasing adoption of minimally invasive cosmetic procedures is expected to support the expansion of the radiofrequency eye device market. These procedures involve treatments that require little or no incision and minimal downtime, providing aesthetic enhancements with quicker recovery and lower risk. The preference for minimally invasive methods is growing as more patients seek safe and effective treatments that do not require extended recovery periods. Radiofrequency eye devices contribute to this trend by delivering controlled radiofrequency energy to the sensitive skin around the eyes, stimulating collagen production, tightening tissues, reducing fine lines and wrinkles, and improving skin texture with precision. These devices offer a non-surgical alternative with minimal recovery time. For example, in June 2023, the American Society of Plastic Surgeons reported that minimally invasive cosmetic procedures increased from 13.7 million to 14.7 million in 2023, marking a 7 percent rise, while surgical procedures rose by 5 percent during the same period. This increasing adoption is driving growth in the radiofrequency eye device market.

Leading companies in the radiofrequency eye device market are advancing artificial intelligence-based technologies for eye diagnostics, such as AI-assisted meibography analysis, to improve diagnostic accuracy and treatment outcomes for conditions such as dry eye and other surface disorders. AI-assisted meibography analysis involves the use of deep learning algorithms to automatically assess the structure and function of the meibomian glands through infrared imaging of the eyelids. This allows for early identification of meibomian gland dysfunction and helps guide more precise treatment plans. In November 2023, Lumenis Ltd., an ophthalmic technology company based in Israel, launched OptiPLUS, a dual-frequency radiofrequency device designed for dry-eye treatment. The system includes features such as automatic electrode detection, preset treatment protocols, and closed-loop temperature control to effectively target meibomian glands while also enhancing collagen around the eyes. This technology allows clinics to combine AI-generated diagnostics with personalized radiofrequency treatments, improving outcomes for patients with ocular surface conditions.

In September 2023, OCULUS Inc., a diagnostic equipment provider based in the United States, formed a partnership with LUVO to bring new intense pulse light and radiofrequency devices to the United States ophthalmic market. Through this collaboration, OCULUS aims to expand its range of treatment solutions, improve care options for eye health professionals, and strengthen its position in the specialty care segment. LUVO is a technology provider based in Canada that offers intense pulse light and radiofrequency devices designed for safe and effective use in clinical eye care.

Major players in the radiofrequency eye device market are Johnson & Johnson Vision, Alcon Inc., Bausch + Lomb, InMode Ltd., Lumenis Ltd., Cynosure Inc., Venus Concept, YA-MAN Ltd., Quantel Medical, Alma Lasers, OCULUS Inc., Guangzhou Beautylife Tech, MiBo Medical Group, ESW Vision, Nidek Co. Ltd., Ziemer, Norlanya, Manhattan Face & Eye, AMIRO, Ophtho India Inc.

North America was the largest region in the radiofrequency eye device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiofrequency eye device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the radiofrequency eye device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A radiofrequency eye device is a medical technology that applies controlled radiofrequency energy to stimulate collagen production and enhance skin elasticity around the eyes. By delivering targeted heat to the underlying tissues, it promotes tightening and reduces visible signs of aging, including fine lines and wrinkles. These devices are designed to offer nonsurgical, minimally invasive eye rejuvenation with minimal recovery time.

The primary product categories of radiofrequency eye devices include monopolar, bipolar, multipolar, and other types. Monopolar RF devices use a single active electrode along with a grounding plate, allowing energy to penetrate deeper into tissues. Distribution channels include direct sales, online retail, and other platforms, with applications such as dry eye therapy, wrinkle reduction, skin tightening, and related treatments. These devices are used by a range of end users, including hospitals, ophthalmic clinics, ambulatory surgical centers, and other healthcare providers.

The radiofrequency eye device market research report is one of a series of new reports that provides radiofrequency eye device market statistics, including radiofrequency eye device industry global market size, regional shares, competitors with a radiofrequency eye device market share, detailed radiofrequency eye device market segments, market trends and opportunities, and any further data you may need to thrive in the radiofrequency eye device industry. The radiofrequency eye device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The radiofrequency eye device market consists of revenues earned by entities by providing services such as non-surgical eye rejuvenation, wrinkle reduction, skin tightening, and overall improvement of skin appearance. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiofrequency eye device market also includes sales of handheld radiofrequency eye treatment devices, tabletop radiofrequency systems, and multi-functional radiofrequency platforms. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.